LAKE LAS VEGAS, Nev., Aug 15, 2008 (BUSINESS WIRE) ----The Noble Financial Capital Markets M.A.D. MAX Equity Conference takes place August 18, 2008 - August 19, 2008 at Loews Lake Las Vegas in Henderson. Listed below are the Noble Financial Capital Markets M.A.D. MAX Equity Conference presenter profiles. For in-depth information about the event, visit http://www.noblemadmax.com/madmaxhome.htm.

Business Wire is the official news wire for the Noble Financial Capital Markets M.A.D. MAX Equity Conference. Breaking news releases and photos are available at http://www.tradeshownews.com, Business Wire's trade show, conference, and event news resource.

 Company: 1-800-PetMeds
   Ticker Symbol & Exchange: PETS Investor Relations Contact: Bruce Rosenbloom Investor Relations Contact Phone: 954-979-5995
   Web: www.1800petmeds.com Date of Presentation: 8/18/08 PetMed Express, Inc. d/b/a 1-800-PetMeds, is a leading nationwide pet
   pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs, cats,
   and horses direct to the consumer. The Company offers consumers an attractive alternative for obtaining pet medications in
   terms of convenience, price, ease of ordering and speed of delivery. The Company markets its products through national television,
   online, and direct mail/print advertising campaigns, which direct the consumers to order by phone or on the internet on its
   website at www.1800petmeds.com, and aim to increase the recognition of the "1- 800-PetMeds" brand name. Company: Access Pharmaceuticals,
   Inc. Ticker Symbol & Exchange: ACCP.OB Investor Relations Contact: Stephen B. Thompson Investor Relations Contact Phone:
   214-905-5100 Web: www.accesspharma.com Date of Presentation: Monday, August 18, 2008 Access Pharmaceuticals, Inc. (ACCP.OB)
   is an emerging pharmaceutical company focused on the development and commercialization of proprietary products for the treatment
   and supportive care of cancer patients. Access has one approved product, MuGard(TM) for the management of oral mucositis.
   The company's lead oncology product is ProLindac(TM), a polymer-linked platinum cancer drug, which is in Phase 2 clinical
   testing in recurrent ovarian cancer patients. Angiolix(R) an antiangiogenic humanized monoclonal antibody, and Prodrax(R),
   a hypoxia-activated prodrug, are the company's lead preclinical oncology products. Access is also developing oral insulin
   and oral hGH using its proprietary Cobalamin(TM) oral drug delivery technology. Company: Allion Healthcare Ticker Symbol &
   Exchange: ALLI / NASDAQ Investor Relations Contact: Rich Cockrell, The Cockrell Group Investor Relations Contact Phone: 404.942.3369
   Web: www.allionhealthcare.com Date of Presentation: 08.18.08 Allion Healthcare, Inc. is a national provider of specialty pharmacy
   and disease management services focused on HIV/AIDS patients as well as specialized biopharmaceutical medications and services
   to chronically ill patients. Allion Healthcare sells HIV/AIDS medications, ancillary drugs and nutritional supplies under
   the trade name MOMS Pharmacy. Allion Healthcare provides services for the intravenous immunoglobulin, Blood Clotting Factor
   and other therapies through its Biomed America division. Allion Healthcare works closely with physicians, nurses, clinics,
   AIDS Service Organizations, and with government and private payors to improve clinical outcomes and reduce treatment costs.
   Company: Alphatec Spine, Inc. Ticker Symbol & Exchange: ATEC Investor Relations Contact: Cheryl Monblatt Investor Relations
   Contact Phone: 760 505 1785 Web: www.alphatecspine.com Date of Presentation: Monday, August 18 Alphatec Spine, Inc. is a wholly
   owned subsidiary of Alphatec Holdings, Inc. (Nasdaq:ATEC). Alphatec Spine is a medical device company involved in the design,
   development, manufacturing and marketing of products for the surgical treatment of spine disorders, with a focus on treating
   disorders related to the aging spine. The company's mission is to combine world-class customer service with innovative, surgeon-driven
   design that will help improve the aging patient's quality of life. The company is poised to achieve its goal through new solutions
   for patients with osteoporosis and other aging spine deformities, improved minimally invasive products and techniques and
   integrated biologics solutions. In addition to its U.S. operations, Alphatec Spine also markets its spine products in Europe.
   Company: American CareSource Holdings, Inc. Ticker Symbol & Exchange: AMEX: XSI Investor Relations Contact: Melody Carey
   Investor Relations Contact Phone: 917-322-2571 Web: www.anci-care.com Date of Presentation: 8/18/2008 American CareSource
   Holdings, the first national, publicly traded ancillary care network services company offers a comprehensive national network
   of approximately 2,500 ancillary service providers at over 25,000 sites. The Company's ancillary network and management provides
   a complete outsourced solution for a wide variety of healthcare payors and plan sponsors including self-insured employers,
   indemnity insurers, PPOs, HMOs, third party administrators and both federal and local governments. For additional information,
   please visit www.anci-care.com. Company: Baldwin Technology Company, Inc. Ticker Symbol & Exchange: AMEX: BLD Investor
   Relations Contact: Helen P. Oster Investor Relations Contact Phone: 203 402 1004 Web: baldwintech.com Date of Presentation:
   8/19/2008 Baldwin is a leading global supplier of process automation systems and associated consumables for the printing and
   publishing industry. Baldwin's broad range of products are designed to enhance the quality, productivity and cost-efficiency
   of the print manufacturing process while addressing environmental concerns and safety issues. Baldwin sells its products both
   to printers to upgrade the quality and capability of their existing presses and to printing press manufacturers who incorporate
   them into their own equipment. Headquartered in Connecticut, Baldwin has product development and production facilities, as
   well as a network of sales and service operations, in strategic markets worldwide. Company: Ballantyne of Omaha, Inc. Ticker
   Symbol & Exchange: AMEX: BTN Investor Relations Contact: Ratula Roy/David Collins Investor Relations Contact Phone: 212-835-8500
   Web: roy@jcir.com Date of Presentation: Monday, Aug. 18, 2008; 11:30 a.m PT For over 70 years, Ballantyne (BTN) has built
   a commanding position and strong customer relationships within the traditional cinema projection market. Now armed with NEC's
   state-of-the art Starus(TM) digital projector line, BTN's leading digital cinema service business and cinema screens and other
   products, BTN is ideally positioned to participate in the cinema industry's largest-ever capital spending program: the conversion
   digital cinema technology. Company: BioScrip, Inc. Ticker Symbol & Exchange: BIOS Nasdaq Investor Relations Contact: Craig
   Allison - Lisa Wilson Investor Relations Contact Phone: 914-460-1636 - 917-543-9932 Web: www.bioscrip.com Date of Presentation:
   8/19/2008 BioScrip is a specialty healthcare organization that partners with patients, physicians, healthcare payors and pharmaceutical
   manufacturers to provide access to medications and management solutions to optimize outcomes for chronic and other complex
   healthcare conditions. Company: BioSphere Medical, Inc. Ticker Symbol & Exchange: BSMD (NASDAQ) Investor Relations Contact:
   Kim Sutton Golodetz Investor Relations Contact Phone: 212-838-3777 Web: www.biospheremed.com Date of Presentation: 8/18/2008
   BioSphere Medical, Inc. seeks to pioneer and commercialize minimally invasive diagnostic and therapeutic applications based
   on proprietary bioengineered microsphere technology. The Company's core technologies, patented bioengineered polymers and
   manufacturing methods, are used to produce microscopic spherical materials with unique beneficial properties for a variety
   of medical applications. BioSphere's principal focus is the treatment of symptomatic uterine fibroids using a procedure called
   uterine fibroid embolization, or UFE. The Company's products continue to gain acceptance in this rapidly emerging procedure,
   as well as in a number of other new and established medical treatments. Company: Bonds.com Group, Inc. Ticker Symbol &
   Exchange: (OTC:BDCG) Investor Relations Contact: Justin Davis Investor Relations Contact Phone: 877-800-BDCG (2324) Web: Justin.Davis@CirrusFC.com
   Date of Presentation: 8/19/2008 Bonds.com Group, Inc., (OTC:BDCG) provides through its broker dealer subsidiary, Bonds.com,
   Inc., an online fixed income trading platform, BondStation. BondStation empowers self directed investors by providing a competitive
   centralized marketplace for the usually illiquid products such as Municipals, Corporates, Agencies, Emerging Market Debt,
   Structured Products and CD's. The company differentiates itself by offering 30,000 unique securities from 175+ competing sources
   at no cost to its clients or liquidity providers. Market research, investor tools, and fixed income educational tools are
   provided at no fee to enhance the customer experience. Our goal is to empower clients with unbiased market information and
   execution capabilities. Company: CBIZ, Inc. Ticker Symbol & Exchange: CBZ Investor Relations Contact: Lori Novickis Investor
   Relations Contact Phone: 216-525-1953 Web: www.cbiz.com Date of Presentation: 8/18/2008 CBIZ, Inc. provides professional business
   services that help clients better manage their finances, employees and technology. As the largest benefits specialist, one
   of the largest accounting, valuation and medical practice management companies in the United States, CBIZ provides its clients
   with financial services which include accounting and tax, internal audit, merger and acquisition advisory, and valuation.
   Employee services include group benefits, property and casualty insurance, payroll, HR consulting and wealth management. CBIZ
   also provides information technology, hardware and software solutions, healthcare consulting and medical practice management.
   These services are provided throughout a network of more than 140 Company offices in 34 states. Company: CombiMatrix Corporation
   Ticker Symbol & Exchange: CBMX (Nasdaq) Investor Relations Contact: Amit Kumar, President & CEO Investor Relations
   Contact Phone: 425-493-2000 Web: www.combimatrix.com Date of Presentation: 8/18/2008 CombiMatrix Corporation is a biotechnology
   company headquartered near Seattle, Washington, USA, with a subsidiary, CombiMatrix Molecular Diagnostics, headquartered in
   Irvine, California. CombiMatrix's patented electrochemical manufacturing process utilizes standard semiconductor technology,
   proprietary software, and chemistry to build arrays of materials -- molecule by molecule. The company's CustomArray(TM) products
   are DNA microarrays, which have uses in pharmaceutical, biotech, and agrochemical industries as well as in research and government
   markets. The company also uses its technology in synergistic internal programs for diagnostics development, drug development,
   and biodefense in addition to partnerships for nanomaterials development. Company: Continucare Corporation Ticker Symbol &
   Exchange: CNU:AMEX Investor Relations Contact: Fernando L. Fernandez Investor Relations Contact Phone: 305-500-2105 Web: www.continucare.com
   Date of Presentation: 8/19/2008 Continucare provides primary care physician services on an outpatient basis through a network
   of medical facilities and independent physician affiliates (IPAs) in the State of Florida. Continucare has 18 medical offices
   equipped with state-of-the-practice technology and staffed with experienced physicians and a comprehensive support staff.
   In addition, Continucare provides health practice management services to IPAs who practice primary care medicine in South
   Florida. Continucare assists these physicians with medical utilization and pharmacy management and specialist network development,
   freeing them to devote more time to patient care. Company: CSMG Technologies Inc. Ticker Symbol & Exchange: CTGI - OTCBB
   Investor Relations Contact: Michael Dodge Investor Relations Contact Phone: 212.495.0744 Web: www.csmgtechinternational.com
   Date of Presentation: 9/19/2008 CSMG Technologies, Inc. is an advanced technology management company engaged in owning, developing,
   patenting, managing, licensing, and marketing. Live Tissue Connect Subsidiary LTC's 400 VAD System, used in human surgery
   to bond / weld soft tissue, replaces sutures, staples and glues, just received FDA clearance. Green Energy CSMG recently acquired
   Carbon Capture Technologies owns worldwide exclusive license to composition and method for use of novel Carbon Dioxide (CO2)
   recyclable adsorbent based on surface modified nanoporous silicas. Potential uses include C02 emissions from coal- fired power
   plants and surgical applications. CSMG's landfill gas technology separates carbon dioxide and other impurities from gas produced
   in landfills. Company: CTG Ticker Symbol & Exchange: Nasdaq: CTGX Investor Relations Contact: James R. Boldt, CEO Investor
   Relations Contact Phone: (716) 888-3634 Web: www.ctg.com Date of Presentation: Tuesday, August 19 CTG provides IT solutions
   and services to help Global 2000 clients focus on their core businesses and use IT as a competitive advantage to excel in
   their markets. CTG combines in-depth understanding of our clients' businesses with a full range of integrated services and
   proprietary ISO 9001:2000-certified service methodologies. Our 3,500 IT professionals based in an international network of
   offices in North America and Europe have a proven track record of delivering high-value, industry-specific solutions. Company:
   Cytori Therapeutics, Inc. Ticker Symbol & Exchange: CYTX -- NASDAQ Investor Relations Contact: Tom Baker Investor Relations
   Contact Phone: 858-458-0900 Web: www.cytoritx.com Date of Presentation: 8/18/2008 Cytori's (NASDAQ: CYTX) goal is to be the
   global leader in regenerative medicine. The company is dedicated to providing patients with new options for reconstructive
   surgery, developing treatments for cardiovascular disease, and banking patients' adult stem and regenerative cells. The Celution(R)
   800 System is being introduced in Europe and Asia Pacific into the reconstructive surgery market while the Celution(R) 900
   System is being commercialized globally for cryopreserving a patient's own stem and regenerative cells. Clinical trials are
   ongoing in cardiovascular disease and planned for spinal disc degeneration, gastrointestinal disorders, and other unmet medical
   needs. www.cytoritx.com Company: EF Johnson Technologies, Inc. Ticker Symbol & Exchange: EFJI Investor Relations Contact:
   Jana Ahlfinger Bell Investor Relations Contact Phone: 972-819-0700 Web: www.efji.com Date of Presentation: 8/18/2008 Headquartered
   in Irving, Texas, EF Johnson Technologies, Inc. focuses on innovating, developing and marketing the highest quality secure
   communications solutions to organizations whose mission is to protect and save lives. The Company's customers include first
   responders in public safety and public service, the federal government, and industrial organizations. The Company's products
   are marketed under the EFJohnson, 3e Technologies International, and Transcrypt International trade names. Company: EMS Technologies,
   Inc. Ticker Symbol & Exchange: ELMG & NASDAQ Investor Relations Contact: Gary Shell Investor Relations Contact Phone:
   770-729-6512 Web: http://www.ems-t.com/ Date of Presentation: Monday, August 18, 2008 EMS Technologies, Inc. (NASDAQ: ELMG)
   is a wireless and satellite communication solutions leader, serving aeronautical, defense, maritime, commercial space and
   supply chain markets. Through its LXE, EMS SATCOM, and Defense & Space Systems divisions, EMS keeps people, systems and
   data connected, wherever they are -- on the ground, in the warehouse, in the air, or in space. The company is headquartered
   in Atlanta, employs approximately 1,000 people worldwide and operates major manufacturing facilities in Atlanta and Ottawa,
   Canada. Company: Etelos, Inc. Ticker Symbol & Exchange: OTCBB: ETLO Investor Relations Contact: Leslie Green Investor
   Relations Contact Phone: 650-312-9060 Web: etelos.com Date of Presentation: 9:30 AM Aug. 19, 2008 Etelos provides on-demand,
   customizable browser-based applications on the hosting environment you choose. Etelos' patent-pending technology for developing
   and deploying on-demand applications is revolutionizing the world of software distribution. The Etelos Marketplace gives developers
   an easy way to license, distribute and host applications. It also gives businesses a wide selection of fully customizable,
   on-demand applications to buy and deploy to the hosting environment of their choice. The Etelos Ecosystem provides all of
   the features of Software as a Service (SaaS) with all the flexibility of custom development. Company: ev3 Inc. Ticker Symbol
   & Exchange: EVVV NASDAQ Investor Relations Contact: Julie Tracy Sr. Vice President Investor Relations Contact Phone: 949-680-1375
   Web: http://www.ev3.net Date of Presentation: 8/18/2008 Since its founding in 2000, ev3 has been dedicated to developing innovative,
   breakthrough and clinically proven technologies and solutions for the treatment of lower extremity vascular and neurovascular
   diseases. ev3's products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular
   diseases and disorders. The company offers a comprehensive portfolio of treatment options, including the primary interventional
   technologies used today - peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid
   embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its products
   can be found at www.ev3.net. Company: Exactech Ticker Symbol & Exchange: Nasdaq EXAC Investor Relations Contact: Hawk
   Associates Investor Relations Contact Phone: Julie Marshall 305.451.1888 Web: www.hawkassociates.com and www.exac.com Date
   of Presentation: 8/18/2008 Exactech is a pure play orthopaedic competitor that is gaining market share in the rapidly expanding
   global biomedical device industry. The company's products are used in the restoration of bones and joints that have deteriorated
   as a result of injury or disease such as arthritis. Exactech develops, manufactures, markets, distributes and sells its orthopaedic
   implant devices, including knee, shoulder, and hip implant systems, related surgical instrumentation and biologic services
   to hospitals and physicians in the United States and internationally in over 30 countries. Founded and led by an orthopaedic
   surgeon, the company has built its success on its customer-centric culture. Feedback and input from its surgeon customers
   have helped Exactech develop a pipeline of innovative products that improve patient outcomes. Company: EXL Service Ticker
   Symbol & Exchange: EXLS Investor Relations Contact: Jarrod Yahes Investor Relations Contact Phone: jarrod.yahes@exlservice.com
   212.277.7109 Web: www.exlservice.com ExlService Holdings, Inc. (Nasdaq: EXLS - News) is a leading provider of Outsourcing
   and Transformation Services. EXL's Outsourcing Services include a full spectrum of business process outsourcing services from
   offshore delivery centers requiring ongoing process management skills. Transformation Services enable continuous improvement
   of client processes by bringing together EXL's capabilities in reengineering including Six Sigma process improvement, research
   & analytics, and risk advisory services. Headquartered in New York, EXL primarily serves the needs of Global 1000 companies
   in the insurance, utilities, financial services, healthcare, telecommunications and transportation sectors. Find additional
   information about EXL at www.exlservice.com. Company: Full House Resorts Ticker Symbol & Exchange: FLL-AMEX Investor Relations
   Contact: Mark Miller Investor Relations Contact Phone: 702-221-7800 Web: http://www.fullhouseresorts.com/ Date of Presentation:
   Monday, August 18, 2008 12 pm PT Full House owns, develops and manages gaming facilities. Full House owns the Stockman's Casino
   in Fallon, Nevada which has 8,400 square feet of gaming space with approximately 260 gaming machines, four table games and
   a keno game. The Company also receives a guaranteed fee from the operation of Harrington Raceway and Casino in Harrington,
   Delaware. Full House also has a management agreement with the Nottawaseppi Huron Band of Potawatomi Indians for the development
   and management of a first-class casino/resort with 2,500 gaming devices, 90 table games and 20 poker tables in the Battle
   Creek, Michigan area - currently under construction. Company: Globex Mining Enterprises Inc. Ticker Symbol & Exchange:
   GMX-TSX, GLBXF-OTCQX Investor Relations Contact: Dan Symons from Renmark Investor Relations Contact Phone: 514-939-3989, ext.
   3323 Web: www.globexmining.com Date of Presentation: August 19th, 2008 Globex is a TSX listed Canadian royalty and exploration
   company with a vast portfolio of wholly owned projects all within North America. The company has few shares issued, cash in
   the bank and no debt. The first quarter of 2008 saw the stat of significant royalty streams as two mines reached production.
   Six others are in pre-production or due diligence. Projects include: copper, zinc, gold, magnesium, talc, nickel, platinum,
   palladium, uranium, rare earths and diamonds. Company: iLinc Ticker Symbol & Exchange: ILC Investor Relations Contact:
   James L. Dunn, Jr. Investor Relations Contact Phone: 602-952-1200 Web: www.ilinc.com Date of Presentation: 8/19/2008 iLinc,
   a recognized leader in web conferencing, desktop video conferencing software and collaboration solutions, aims to revolutionize
   the way organizations meet and communicate. Through its software and services, iLinc liberates people by enabling them to
   get more done, travel less, achieve work-life balance while preserving the environment. iLinc offers the only enterprise-class
   web and video conferencing software that allows customers to choose between a software-as-a-service (SaaS) rental model or
   a traditional software purchase model, in combination with hosting by iLinc or on-premise installation. iLinc is headquartered
   in Phoenix, Arizona. For more visit www.ilinc.com/investors. Company: Inspire Pharmaceuticals Ticker Symbol & Exchange:
   ISPH Investor Relations Contact: Jenny Kobin Investor Relations Contact Phone: 919 287-1219 Web: www.inspirepharm.com Date
   of Presentation: 8/18/2008 Inspire is a biopharmaceutical company dedicated to discovering, developing and commercializing
   prescription pharmaceutical products for ophthalmic and pulmonary diseases. Inspire employs a U.S. sales force for the promotion
   of AzaSite(R) (azithromycin ophthalmic solution) 1% for bacterial conjunctivitis, Elestat(R) (epinastine HCI ophthalmic solution)
   0.05% for allergic conjunctivitis and Restasis(R) (cyclosporine ophthalmic emulsion) 0.05% for dry eye. Inspire is currently
   developing products for dry eye, cystic fibrosis and glaucoma. Elestat, Restasis and Prolacria are trademarks owned by Allergan,
   Inc. AzaSite is a trademark owned by InSite Vision Incorporated. For more information, visit www.inspirepharm.com. Company:
   KRATOS DEFENSE & SECURITY SOLUTIONS, INC Ticker Symbol & Exchange: NASDAQ: KTOS Investor Relations Contact: MICHAEL
   BAEHR, VP of IR Investor Relations Contact Phone: (858) 812-7366 Web: WWW.KRATOSDEFENSE.COM Date of Presentation: AUG. 18
   Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS) is a leading national defense, information technology and homeland
   security solutions provider. The Company primarily performs work for the U.S. federal government, but also for various state
   and local agencies. Principle services include C5ISR, weapon systems life cycle support, military range operations and technical
   services, missile, rocket and weapon systems test & evaluation, advanced network engineering and IT services, security
   and surveillance integration, and critical infrastructure design and integration. The Company is headquartered in San Diego,
   California, with resources throughout the U.S. and at key strategic military locations. Company: MediaNet Group Technologies,
   Inc. Ticker Symbol & Exchange: (OTCBB: MEDG) Investor Relations Contact: Martin Berns Investor Relations Contact Phone:
   954-974-5818 ext. 202 Web: www.medianetgroup.com Date of Presentation: 8/19/08 12:30 p.m. PST MediaNet Group Technologies,
   Inc. (OTCBB: MEDG), through its BSP Rewards division, has developed the Internet's largest mall and affinity program platform.
   BSP builds, brands, customizes and administers proprietary loyalty/rewards/mall programs for each client and organization
   and is also a value added element layered onto debit and stored value cards. BSP Rewards creates private branded versions
   of the mall for clients that enroll their database of members and they then promote the mall to their members. Benefits to
   clients include customer acquisition, incentive and retention, loyalty programs, enhanced sales and potential new and recurring
   revenue-- turning operational costs into profit centers. Company: Merit Medical Systems, Inc. Ticker Symbol & Exchange:
   NASDAQ: MMSI Investor Relations Contact: Anne-Marie Wright Investor Relations Contact Phone: (801) 208-4167 Web: www.merit.com
   Date of Presentation: 8/18/2008 Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and
   distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology
   and radiology. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately
   90 individuals. Merit employs approximately 1,600 people worldwide, with facilities in Salt Lake City and South Jordan, Utah;
   Angleton, Texas; Richmond, Virginia; Maastricht and Venlo, The Netherlands; and Galway, Ireland. Company: Misonix, Inc. Ticker
   Symbol & Exchange: Nasdaq: MSON Investor Relations Contact: Kevin McGrath Investor Relations Contact Phone: 212-245-4577
   Web: www.misonix.com Date of Presentation: August 19, 2008 at 8:30am PT Misonix, Inc. (NASDAQ: MSON) designs, develops, manufactures
   and markets therapeutic ultrasonic medical devices and laboratory equipment. Misonix's therapeutic ultrasonic platform is
   the basis for several innovative medical technologies. These devices include High Intensity Focused Ultrasound for the treatment
   of tumors, soft tissue aspirators, laparoscopic cutting and coagulation instruments, and surgical aspirators. Addressing a
   combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used
   for wound debridement, cosmetic surgery, spinal surgery, neurosurgery, laparoscopic surgery, and other surgical and medical
   applications. Company: MTR Gaming Ticker Symbol & Exchange: (NASDAQ:MNTG) Investor Relations Contact: Melissa Dixon Investor
   Relations Contact Phone: 212-836-9613 Web: www.mtrgaming.com Date of Presentation: 8/18/2008 MTR Gaming Group, Inc., through
   subsidiaries, owns and operates Mountaineer Casino, Racetrack & Resort in Chester, WV; Presque Isle Downs & Casino
   in Erie, PA; and Scioto Downs in Columbus, OH. The Company also owns a 90% interest in Jackson Trotting Association, LLC,
   which operates Jackson Harness Raceway in Jackson, MI, and a 50% interest in the North Metro Harness Initiative, LLC, which
   operates Running Aces Harness Park in Minneapolis, MN. Running Aces Harness Park racetrack commenced racing in April 2008
   and opened a 50-table card room on June 30, 2008. For more information, please visit www.mtrgaming.com. Company: National
   Lampoon Ticker Symbol & Exchange: NLN AMEX Investor Relations Contact: Howard Gostfriend Investor Relations Contact Phone:
   305-918-7000 Web: info@amcapventures.com Date of Presentation: 8/18/2008 National Lampoon, Inc. has been a dominant force
   in the comedy world for almost 40 years, and is currently active in a broad array of media and entertainment segments. These
   include feature films, Internet and online entertainment, television programming, home video, audio, and book publishing.
   The Company also owns interests in all major National Lampoon properties, including National Lampoon's Animal House, the National
   Lampoon Vacation series and National Lampoon's Van Wilder. National Lampoon reaches nearly one in four of all 18 to 24 year
   old college students in America today. These include the National Lampoon Humor Network - the most trafficked humor sites
   on the web, the Drunk University Network, the new ZAZ Network, and the National Lampoon Video Network, which includes channels
   on YouTube, Yahoo, Veoh, and Lycos. Company: Neogenomics, Inc. Ticker Symbol & Exchange: OTCBB: NGNM Investor Relations
   Contact: Neogenomics Investor Relations Contact Phone: Steven Jones - (239) 325-2001 Web: www.neogenomics.org Date of Presentation:
   Monday, Aug. 18, 2008 1:30 p.m. NeoGenomics, is a high-complexity CLIA-certified clinical laboratory that specializes in cancer
   genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include
   cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular
   genetic testing. Headquartered in Fort Myers, FL, NeoGenomics also has labs in Nashville, Tenn. and Irvine, Calif. and services
   the needs of pathologists, oncologists, urologists, and hospitals throughout the United States. Company: Novelos Therapeutics,
   Inc. Ticker Symbol & Exchange: NVLT OTCBB Investor Relations Contact: Stephen Lichaw Investor Relations Contact Phone:
   201-240-3200 Web: www.novelos.com Date of Presentation: August 18, 2008, 11am PDT Novelos is a biopharmaceutical company commercializing
   oxidized glutathione-based compounds for the treatment of cancer and hepatitis. NOV-002, the lead compound currently in Phase
   3 development for lung cancer under a SPA and Fast Track, acts together with chemotherapy as a chemoprotectant and a chemopotentiator.
   NOV- 002 is also in Phase 2 development for chemotherapy-resistant ovarian cancer and early-stage breast cancer. NOV-205 acts
   as a hepatoprotective agent with immunomodulating and anti-inflammatory properties. NOV-205 is in Phase 1b development for
   chronic hepatitis C non-responders. Both compounds completed clinical trials in humans and were approved in Russia where they
   were originally developed. Company: OmniComm Systems, Inc. Ticker Symbol & Exchange: OMCM.OB Investor Relations Contact:
   Ronald Linares, CFO Investor Relations Contact Phone: Ronald Linares, CFO 954-473-1254 Web: www.omnicomm.com Date of Presentation:
   Tuesday, August 19, 2008 at 7:30 AM OmniComm Systems, Inc. is an eClinical software and services company dedicated to helping
   pharmaceutical, biotechnology, CRO, research and medical device organizations to maximize the value of their clinical research
   investments through the use of innovative and progressive technologies. The company has corporate headquarters located in
   Ft. Lauderdale, Florida and offices in Bonn, Germany, Tula, Russia, California, Maryland, New York, North Carolina and Texas.
   Founded in 1997, with a systems integration focus and an EDC solution built for clinical research conducted at Mt. Sinai Hospital,
   we have continued to develop our product pipeline and services to meet the evolving needs of the drug development marketplace.
   Company: PHC, Inc. d/b/a Pioneer Behavioral Healt Ticker Symbol & Exchange: AMEX: PHC Investor Relations Contact: Liolios
   Group Investor Relations Contact Phone: (949) 574-3860 Web: www.phc-inc.com Date of Presentation: August 19 at 7:30 a.m. Pacific
   Time PHC, Inc. d/b/a Pioneer Behavioral Health is an emerging national healthcare company providing behavioral health services
   through contracts with government agencies, national insurance companies, as well as major transportation and gaming companies.
   Pioneer to helps people gain and maintain physical, spiritual and emotional health. The company achieves this by developing
   and delivering the highest quality, most culturally responsive, compassionate and competitive services to individuals, corporations,
   and the community. Pioneer operates in three complementary business operating units: hospital and clinical services; integrated
   delivery services; and clinical research. Company: Pipex Pharmaceuticals, Inc. Ticker Symbol & Exchange: AMEX: PP Investor
   Relations Contact: Thomas Redington Investor Relations Contact Phone: 203-222-7399 Web: www.pipexinc.com Date of Presentation:
   8/18/2008 Pipex Pharmaceuticals, Inc. is a specialty pharmaceutical company that is developing proprietary, late-stage drug
   candidates for the treatment of central nervous system (CNS) and autoimmune diseases. Pipex's strategy is to exclusively in-license
   proprietary, clinical- stage drug candidates and to complete the further clinical testing, manufacturing and regulatory requirements
   and seek marketing authorizations. Pipex is focused on treating Dry Age-Related Macular Degeneration (AMD), multiple sclerosis
   (MS), Rheumatoid Arthritis (RA) and fibromyalgia. Company: Pluristem Therapeutics, Inc. Ticker Symbol & Exchange: PSTI:
   NASDAQ Investor Relations Contact: William R. Prather RPh, MD Investor Relations Contact Phone: 303-883-4954 Web: Pluristem.com
   Date of Presentation: 8/19/2008 Pluristem Therapeutics Inc. is dedicated to the commercialization of non-personalized (allogeneic)
   cellular therapeutics for degenerative, ischemic and autoimmune indications. The Company's pipeline of products, stored ready-to-use
   and without HLA matching needed, are derived from the human placenta, a non-controversial, non-embryonic, adult stem cell
   source. These placental cells are expanded in the Company's proprietary PluriXTM 3D bioreactor, emulating bone-marrow, and
   not requiring supplemental growth factors. Pluristem believes that the resultant PLX (PLacental eXpanded) cells are able to
   differentiate into a variety of cell types. Pluristem's first product, PLX-PAD, to treat limb ischemia, enters human trials
   in the fall of 2008. Company: Point.360 Ticker Symbol & Exchange: PTSX - NASDAQ Global Investor Relations Contact: Alan
   Steel Investor Relations Contact Phone: 818-565-1444 Web: asteel@point360.com Date of Presentation: 8/18/2008 Point.360 is
   a value add service organization specializing in content creation, manipulation and distribution processes integrating complex
   technologies to solve problems in the life cycle of Rich Media. With six locations in greater Los Angeles, Point.360 performs
   high and standard definition audio and video post production, creates virtual effects and archives and distributes physical
   and electronic Rich Media content worldwide, serving studios, independent producers, advertising agencies, corporations, non-profit
   organizations and governmental agencies. Company: PokerTek, Inc. Ticker Symbol & Exchange: PTEK (NASDAQ) Investor Relations
   Contact: Mark Roberson Investor Relations Contact Phone: (704) 84-0860, x101 Web: www.pokertek.com Date of Presentation: 8/18/2008
   PokerTek, Inc. (NASDAQ: PTEK ) is the industry pioneer and worldwide leader in automated poker tables and related software.
   PokerTek develops and markets PokerPro automated poker tables and related software applications developed to increase casino
   revenue, reduce expenses and attract new players into poker rooms. PokerTek also entered the amusement space by introducing
   Heads-Up Challenge(TM), a heads-up poker table for bars and restaurants that targets adults who play for amusement only. PokerPro
   tables are located in the United States, Canada, Panama, Germany, Australia, Bulgaria, South Africa and several major cruise
   lines. Company: SmartPros Ltd. Ticker Symbol & Exchange: SPRO Investor Relations Contact: Shane Gillispie Investor Relations
   Contact Phone: 914-752-4401 Web: www.smartpros.com Date of Presentation: 8/19 Founded in 1981, SmartPros Ltd. is an industry
   leader in the field of accredited professional education and corporate training. Its products and services are primarily focused
   in the accredited professional areas of corporate accounting, financial management, public accounting, governmental and not-for-profit
   accounting, financial services, banking, engineering, legal, ethics and compliance, and information technology. SmartPros
   is a leading provider of professional education products to Fortune 500 companies, as well as the major firms and associations
   in each of its professional markets. SmartPros provides education and content publishing and development services in a variety
   of media including Web, CD-ROM and video. Company: Synergetics USA, Inc. Ticker Symbol & Exchange: SURG Investor Relations
   Contact: Pamela G. Boone Investor Relations Contact Phone: 636-794-5018 Web: www.synergeticsusa.com Date of Presentation:
   8/19/2008 Synergetics USA, Inc. is a leading medical device company focused on progressing the standard of care for microsurgeons
   and their patients. The Company seeks to improve surgical patient outcomes through the delivery of product innovations related
   to improvements in quality, delivery and cost by focusing on ophthalmology and neurosurgery. Its distribution channels include
   a combination of direct and independent sales organizations and important strategic alliances with market leaders. The Company's
   product lines focus upon precision engineered, microsurgical, hand-held instruments and the microscopic delivery of laser
   energy, ultrasound, electrosurgery, illumination and irrigation, often delivered in multiple combinations. Company: TeleCommunication
   Systems, Inc. Ticker Symbol & Exchange: NASDAQ GM: TSYS Investor Relations Contact: Liolios Group Investor Relations Contact
   Phone: 949-574-3860 Web: www1.telecomsys.com/ Date of Presentation: 8/19/2008 TeleCommunication Systems, Inc. (TCS) engineers
   and delivers highly reliable wireless communications technology. TCS provides wireless and VoIP E9-1-1 network-based services,
   secure deployable communication systems, engineered satellite-based services, and commercial location applications, like traffic
   and navigation, using the precise location of a wireless device. Customers include leading wireless, cable and VoIP carriers
   around the world and agencies of the U.S. Departments of Defense, State, and Homeland Security. TCS is one of six primary
   vendors on a $5 billion Army Worldwide Satellite Systems Contract vehicle. Its 500 employees are based primarily in Annapolis,
   Seattle, Oakland, and Tampa. Company: The Quantum Group, Inc. Ticker Symbol & Exchange: AMEX: QGP Investor Relations Contact:
   Danielle Amodio Investor Relations Contact Phone: 561.798.9800 Web: www.QuantumMD.com Date of Presentation: 8/18/2008 The
   Quantum Group provides business process solutions, service chain management, strategic consulting and leading edge technology
   innovations to the healthcare industry. We are guided by a mission to develop efficiencies, improve the quality of patient
   care and achieve cost reductions for the nation's largest and fastest growing industry. We have developed leading-edge technology
   with the creation and deployment of a series of innovative patent-pending initiatives. Through approximately 2,000 healthcare
   providers and multiple insurance company relationships under management, we are positioned to be a catalyst for change to
   the Florida healthcare industry. Company: Tix Corporation Ticker Symbol & Exchange: NasdaqCM: TIXC Investor Relations
   Contact: Elin Chistyakov Investor Relations Contact Phone: 310-954-1110 Web: elin.chistyakov@icrinc.com Date of Presentation:
   Tuesday, August 19 Tix Corporation is an integrated entertainment organization offering discount ticketing through its Tix4Tonight
   operation in Las Vegas, where it dominates that market and is expanding nationally; premium ticketing services; event merchandising
   such as owning and operating the museum stores for the traveling King Tut exhibits; and live theatrical production and promotion
   throughout the US and Canada. In the first quarter of 2008, revenue increased to a record $23.2 million from $1.75 in the
   prior year period, and net income was $461,000, or $0.01 per diluted share. The Company had a positive cash flow from operations
   in the amount of approximately $2.6 million, a cash balance of $6.6 million and no debt at March 31, 2008. Company: TMNG Global
   Ticker Symbol & Exchange: Nasdaq: TMNG Investor Relations Contact: Corey Kinger Investor Relations Contact Phone: 212-986-6667
   Web: www.tmng.com Date of Presentation: 8/19/08 TMNG Global (NASDAQ: TMNG) is a leading provider of professional services
   to the converging communications industry. Its companies, TMNG, CSMG, Cartesian, and TWG Consulting, and its base of over
   600 consultants, have provided strategy, management, and technical consulting, as well as products and services, to more than
   1200 communications service providers, entertainment, media, and technology companies and financial services firms worldwide.
   The company is headquartered in Overland Park, Kansas, with offices in Boston, Chicago, London, New Jersey, New York, Shanghai
   and Washington, D. C. Company: Tri-Isthmus Group, Inc. Ticker Symbol & Exchange: Pink Sheets: TISG Investor Relations
   Contact: Hawk Associates Investor Relations Contact Phone: Antonella Montagna - (305) 451- 1888 Web: www.tig3.com Date of
   Presentation: Monday, August 18, 1:30 p.m. TIGroup partners with and provides financial, operational and technological services
   to physician-owned businesses. The company promotes quality medical care, efficiency and profitability for their physician-partners
   and investors. Their services improve access, quality and breadth of healthcare services in non-urban markets. TIGroup is
   building a diversified portfolio of interests in healthcare services operations, including rural hospitals, physician practices,
   clinics, and ambulatory surgical centers. The Los Angeles- based company operates several medical facilities and employs over
   300 people in Oklahoma and California. Company: Zix Corporation Ticker Symbol & Exchange: Nasdaq: ZIXI Investor Relations
   Contact: Peter Wilensky Investor Relations Contact Phone: 214-515-7357 Web: www.zixcorp.com Date of Presentation: 8/19/2008
   ZixCorp is a leading provider of hosted Internet applications, offered in a Software as a Service (SaaS) model, that require
   high availability, reliability, integrity, and -- particularly -- security. We currently target two lines of business: ZixCorp's
   hosted Email Encryption Service provides an easy and cost-effective way to ensure customer privacy and regulatory compliance
   for corporate email. Its PocketScript(R) e-prescribing service saves lives and saves money by automating the prescription
   process between payors, doctors and pharmacies, and provides a platform for additional functionality by creating a real-time
   connection to physicians at the point of care. 

Note to Editors: Business Wire's PressPass allows you to create free, custom Web, RSS, and email-based news feeds from more than 160 industry options, dozens of subject categories and thousands of geographic preferences as well as by specific company filters. In addition, PressPass subscribers have access to exclusive content, experts, company profiles, email alerts, survey services and other media services.

Note to Event Organizers: Add your trade show, conference, or event to http://www.tradeshownews.com, Business Wire's online event calendar. For information, email tradeshow (at) businesswire.com.

SOURCE: Business Wire Global Event Services

Business Wire Global Event
   Services 310-820-9473 

Copyright Business Wire 2008